GSTM1 and chronic kidney disease: Notably, a meta-analysis of six clinical studies comparing the efficacy of i.v. and oral iron treatments in patients with ND-CKD showed statistically significantly better outcomes in Hb, serum ferritin and TSAT in i.v. iron-treated patients [25].